ICRA | azlyrics.org.uk

ICRA cuts outlook on Indian pharma

Posted on

ICRA has revised its outlook on the domestic pharmaceutical industry from stable to negative in view of the lockouts in parts of China, amid the coronavirus outbreak. Of the total imports of active pharmaceutical ingredients and intermediates into India, China accounts for 65-70%, while in specific APIs, the dependence is as high as 80-90%.